Global haemostasis and point of care testing

Correlation between Standard Clinical Chemistry and Point of Care Testing Analyzers on Hemoglobin A1C Determination

Point-of-Care Diagnostic Testing in Global Health: What Is the Point?

Although point-of-care (POC) testing is widely considered a good idea, there is little agreement on what exactly it entails. While regulatory agencies such as the U.S. Food and Drug Administration (FDA) categorize tests based on criteria such as complexity and Clinical Laboratory Improvement Amendments (CLIA) waivers, the choice of criteria becomes vastlymore complexwhenmoving from issues conce...

Point-of-Care Testing and Creatinine Measurement.

This paper reviews the current status of point-of-care testing (PoCT) devices that are available for measuring whole blood or serum/plasma creatinine globally and within Australasia. Information on non-analytical specifications and analytical performance is provided using data sourced from recently published literature, external quality assurance programs and evaluative work by the author's uni...

Microfluidics and point-of-care testing.

In many ways, the intrinsic features of microfluidics are a natural fit for a pointof-care (POC) diagnostics device (i.e. a diagnostic test performed near the patient without needing a clinical lab): low consumption of reagents and sample, miniaturization of device, and fast turnaround time for analysis. Thus, it comes as no surprise that much research, since the inception of modern microfluidi...

Field effect transistor nanobiosensors: State-of-the-art and key challenges as point of care testing devices

The existing health care systems focus on treating diseases rather than preventing them. Patients are generally not tested unless physiological symptoms are appeared. When they do get tested, the results often take several days and can be inconclusive if the disease is at an early stage. In order to facilitate the diagnostics process and make tests more readily available for patients, the conce...